We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
There are cancers unique to women, such as gynecologic cancers and the majority of breast cancers. Gynecologic cancer is any cancer that starts in a woman’s reproductive organs. There are five main types of gynecologic cancers: cervical, ovarian, uterine, vaginal and vulvar. Breast Cancer, while not unique to women, is the 2nd most common type of cancer in women.
We are currently investigating experimental medications to treat women’s cancers, including gynecologic cancers and ER+/HER2- breast cancer.
Gynecologic cancers begin in different places within a woman’s pelvis, which is the area below the stomach and in between the hipbones. Each gynecologic cancer is unique and has its own signs, symptoms and risk factors.
About 1 in 8 women will have invasive breast cancer at some point in their lives (cancer that has spread to areas outside the area where cancer started). Approximately 80% of all breast cancers are ER+ and about 20% are HER2-. Knowing your Hormone Receptor type is very important in the treatment of breast cancer.
There is much research focused on identifying the unique characteristics of the many different types of cancers. Terms such as personalized, targeted, and precision medicine is often used in cancer-related communications. These terms refer to all the research and discoveries that support the identification of treatments based on unique characteristics of your particular cancer. You may also have heard the term ‘biomarker’. Through research, many biomarkers (also called ‘tumor markers’ when referring to cancer) have been identified and reflect some of the unique characteristics in your blood, urine and/or tissue. Some biomarkers that you may have heard of in women’s cancers are types of molecules, such as the following, with examples:
These all indicate something about your condition and may help your doctor address your unique needs. Our research studies continue to work to build on the currently knowledge of biomarkers, by investigating the potential of additional biomarkers to improve care.
Thank you for Considering a Clinical Trial
Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).
Here are some options for you to find more information:
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
A Study to Assess DF6002 (BMS-986415) Alone and in Combination With Nivolumab in Participants With Locally Advanced or Metastatic Solid Tumors
A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
Bristol Myers Squibb is not affiliated with the creators of this content. The information provided here is for informational purposes only and is not meant to replace a physician's medical advice or imply endorsement. Content in this video may speak to medical topics that are not necessarily related to clinical trials.
Used with permission of the Society of Gynecologic Oncology and Foundation for Women’s Cancer. SGO and FWC permission does not constitute endorsement of company products or services.Gynecologic Cancer Clinical Trials: What This Means for You 19:00
Just as cancer affects your physical health, it can bring up a wide range of feelings you’re not used to dealing with. It can also make existing feelings seem more intense. They may change daily, hourly, or even minute to minute. This is true whether you’re currently in treatment, done with treatment, or a friend or family member. These feelings are all normal.
Often the values you grew up with affect how you think about and cope with cancer. For example some people:
Whatever you decide, it's important to do what's right for you and not to compare yourself with others. Your friends and family members may share some of the same feelings. If you feel comfortable, share this information with them.
More about Feelings and Cancer, originally published by the National Cancer Institute.
If you are helping your family member or friend through cancer treatment, you are a caregiver. This may mean helping with daily activities such as going to the doctor or making meals. It could also mean coordinating services and care. Or it may be giving emotional and spiritual support. The tips below are for most cancer caregivers. But there are also more details available for caregivers dealing with advanced cancer, caregiving after treatment ends, for parents with a child with cancer, and for teens with a family member with cancer.
Bristol Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.
divider
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information